The invention relates to new crystalline forms of tiotropium bromide, processes for preparing them and their use for preparing a pharmaceutical composition for the treatment of respiratory complaints, particularly for the treatment of COPD (chronic obstructive pulmonary disease) and asthma.
申请公布号
WO2006117300(A3)
申请公布日期
2007.04.26
申请号
WO2006EP61765
申请日期
2006.04.21
申请人
BOEHRINGER INGELHEIM INTERNATIONAL GMBH;BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG;MORISSETTE, SHERRY L.;TAWA, MARK D.;OLIVEIRA, MARK A.
发明人
MORISSETTE, SHERRY L.;TAWA, MARK D.;OLIVEIRA, MARK A.